<p>Intellia Therapeutics, Inc.（纳斯达克代码：NTLA）是一家领先的临床阶段基因编辑公司，已根据纳斯达克上市规则 5635(c)(4) 宣布了诱导性授予。该公司向新员工授予了股票期权和限制性股票单位（RSU），作为其薪酬方案的一部分。这一举措与 Intellia 的长期战略目标和财务预测相一致，同时也体现了其吸引和留住生物技术领域顶尖人才的承诺。</p>
<p>诱导性授予包括股票期权和限制性股票单位（RSU），旨在将新员工的利益与公司股东的利益对齐。通过提供这些授予，Intellia 展示了其对员工投资的承诺，并促进创新和成功的文化。这些授予预计会对公司的流通股产生稀释影响，但由于为这些奖励保留的股份数量相对较小，因此稀释影响预计不会显著。</p>
<p>在财务预测方面，这些诱导性授予预计会对公司的流通股产生稀释影响。然而，由于为这些奖励保留的股份数量相对较小，因此稀释影响预计不会显著。此外，这些授予旨在基于绩效，即只有在达到特定绩效目标时，受赠者才能完全获得股份。这种利益对齐有助于确保新员工专注于推动公司的成功，并为其长期财务预测做出贡献。</p>
<p>总之，诱导性授予通过吸引和留住顶尖人才、促进创新文化以及将新员工的利益与公司股东的利益对齐，与 Intellia Therapeutics 的长期战略目标和财务预测相一致。这些授予预计会产生稀释影响，但不会显著，并且它们旨在基于绩效，进一步增强与公司目标的对齐。</p>
<p><img src="https://imageproxy.pbkrs.com/https://lh-prod-oper-pub-opercenter.s3.amazonaws.com/discovery-image/compress-1a539c8fbb538001.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://lh-prod-oper-pub-opercenter.s3.amazonaws.com/discovery-image/compress-1a539c8fbb538001.png"/></p>

Intellia治疗

<p>Intellia Therapeutics, Inc. 宣布根据纳斯达克上市规则 5635(c)(4) 向新员工授予股票期权和限制性股票单位（RSUs）的激励计划。此举旨在吸引和留住人才，同时使员工的利益与股东保持一致。尽管这些授予可能会导致一定程度的股份稀释，但预计影响将是微乎其微的。这些授予的绩效基础特性确保员工只有在达到特定目标后才能获得股份，从而支持公司的长期战略目标和财务预测</p>

<p>Intellia Therapeutics, Inc. (NASDAQ: NTLA), a leading clinical-stage gene editing company, has announced inducement grants under Nasdaq Listing Rule 5635(c)(4). The company granted stock options and restricted stock units (RSUs) to new employees as part of their compensation packages. This move aligns with Intellia's long-term strategic goals and financial projections, as well as its commitment to attracting and retaining top talent in the biotechnology sector.</p>
<div class="lb-trans"><p>Intellia Therapeutics, Inc.（纳斯达克代码：NTLA）是一家领先的临床阶段基因编辑公司，已根据纳斯达克上市规则 5635(c)(4) 宣布了诱导性授予。该公司向新员工授予了股票期权和限制性股票单位（RSU），作为其薪酬方案的一部分。这一举措与 Intellia 的长期战略目标和财务预测相一致，同时也体现了其吸引和留住生物技术领域顶尖人才的承诺。</p>
</div><p>The inducement grants consist of stock options and RSUs, which are intended to align the interests of new employees with those of the company's shareholders. By offering these grants, intellia is demonstrating its commitment to investing in its employees and fostering a culture of innovation and success. The grants are expected to be dilutive to the company's outstanding shares, but the dilution is not expected to be significant, as the number of shares reserved for these awards is relatively small compared to the company's total outstanding shares.</p>
<div class="lb-trans"><p>诱导性授予包括股票期权和限制性股票单位（RSU），旨在将新员工的利益与公司股东的利益对齐。通过提供这些授予，Intellia 展示了其对员工投资的承诺，并促进创新和成功的文化。这些授予预计会对公司的流通股产生稀释影响，但由于为这些奖励保留的股份数量相对较小，因此稀释影响预计不会显著。</p>
</div><p>In terms of financial projections, these inducement grants are expected to be dilutive to the company's outstanding shares. However, the dilution is not expected to be significant, as the number of shares reserved for these awards is relatively small compared to the company's total outstanding shares. Moreover, the grants are intended to be performance-based, meaning that the recipients will only fully vest in the shares if they meet certain performance targets. This alignment of interests helps to ensure that the new employees are focused on driving the company's success and contributing to its long-term financial projections.</p>
<div class="lb-trans"><p>在财务预测方面，这些诱导性授予预计会对公司的流通股产生稀释影响。然而，由于为这些奖励保留的股份数量相对较小，因此稀释影响预计不会显著。此外，这些授予旨在基于绩效，即只有在达到特定绩效目标时，受赠者才能完全获得股份。这种利益对齐有助于确保新员工专注于推动公司的成功，并为其长期财务预测做出贡献。</p>
</div><p>In summary, the inducement grants align with Intellia Therapeutics' long-term strategic goals and financial projections by attracting and retaining top talent, fostering a culture of innovation, and aligning the interests of new employees with those of the company's shareholders. The grants are expected to be dilutive but not significantly so, and they are designed to be performance-based, further enhancing their alignment with the company's objectives.</p>
<div class="lb-trans"><p>总之，诱导性授予通过吸引和留住顶尖人才、促进创新文化以及将新员工的利益与公司股东的利益对齐，与 Intellia Therapeutics 的长期战略目标和财务预测相一致。这些授予预计会产生稀释影响，但不会显著，并且它们旨在基于绩效，进一步增强与公司目标的对齐。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://lh-prod-oper-pub-opercenter.s3.amazonaws.com/discovery-image/compress-1a539c8fbb538001.png" alt="" original-src="https://lh-prod-oper-pub-opercenter.s3.amazonaws.com/discovery-image/compress-1a539c8fbb538001.png"/></p>

Intellia 治疗通过股票期权和限制性股票单位（RSU）提升员工激励